 ACTON, Mass.--BUSINESS WIRE--Insulet Corporation NASDAQ: PODD Insulet or the Company, the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced positive results from the first pivotal trial for the Omnipod 5 Automated Insulin Delivery System. Omnipod 5, the worlds first tubeless, wearable system that continuously adapts insulin delivery based on glucose levels and trends, significantly improved time in range and reduced HbA1c in children, 